Pretreatment neutrophil-to-lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration-sensitive prostate cancer.
Samer SalahRamiz Abu-HijlihFawzi AbuhijlaFaris TamimiAbdallah Al-TellMohammed ShahaitPublished in: Cancer reports (Hoboken, N.J.) (2021)
Elevated pretreatment NLR independently predicts inferior OS in newly diagnosed patients with mCSPC. However, NLR was not a predictor of time to PSA progression.